Difference between revisions of "Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2) (Q10992)"
Jump to navigation
Jump to search
(Created claim: named entity (P78): Arrhythmias, Cardiac (disease - MeSH descriptor) (Q10939), #quickstatements; #temporary_batch_1592939248955) |
(Removed claim: named entity (P78): COVID-19 (disease - MeSH supplementary concept) (Q7804)) |
||
(6 intermediate revisions by the same user not shown) | |||
Property / named entity | |||
+ | |||
Property / named entity: Thomas syndrome (disease - MeSH supplementary concept) / rank | |||
+ | Normal rank | ||
Property / named entity | |||
+ | |||
Property / named entity: Human (species) / rank | |||
+ | Normal rank | ||
Property / named entity | |||
+ | |||
Property / named entity: 2019 novel coronavirus (species) / rank | |||
+ | Normal rank | ||
Property / named entity | |||
+ | |||
Property / named entity: Heart Failure (disease - MeSH descriptor) / rank | |||
+ | Normal rank | ||
Property / Collection or Dataset of Origin | |||
+ | |||
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank | |||
+ | Normal rank |
Latest revision as of 23:41, 20 October 2020
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
Language | Label | Description | Also known as |
---|---|---|---|
English |
Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2)
|
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
|
Statements
0 references
0 references
0 references